128 related articles for article (PubMed ID: 21623942)
41. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
[TBL] [Abstract][Full Text] [Related]
42. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
Stöckle M
Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
[TBL] [Abstract][Full Text] [Related]
43. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
May M; Herrmann E; Bolenz C; Tiemann A; Brookman-May S; Fritsche HM; Burger M; Buchner A; Gratzke C; Wülfing C; Trojan L; Ellinger J; Tilki D; Gilfrich C; Höfner T; Roigas J; Zacharias M; Gunia S; Wieland WF; Hohenfellner M; Michel MS; Haferkamp A; Müller SC; Stief CG; Bastian PJ
Eur Urol; 2011 May; 59(5):712-8. PubMed ID: 21296488
[TBL] [Abstract][Full Text] [Related]
44. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.
Sanderson KM; Stein JP; Skinner DG
Urol Oncol; 2004; 22(3):205-11; discussion 212-3. PubMed ID: 15271318
[TBL] [Abstract][Full Text] [Related]
45. Radical cystectomy for stage T3b bladder cancer.
Hall CM; Dinney CP
Semin Urol Oncol; 1996 May; 14(2):73-80. PubMed ID: 8734734
[TBL] [Abstract][Full Text] [Related]
46. [Ranking of pelvic lymphadenectomy in therapy and prognosis of carcinoma of the bladder].
Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
Aktuelle Urol; 2003 Oct; 34(6):392-7. PubMed ID: 14579186
[TBL] [Abstract][Full Text] [Related]
47. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
[TBL] [Abstract][Full Text] [Related]
48. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Hellenthal NJ; Hussain A; Andrews PE; Carpentier P; Castle E; Dasgupta P; Kaouk J; Khan S; Kibel A; Kim H; Manoharan M; Menon M; Mottrie A; Ornstein D; Palou J; Peabody J; Pruthi R; Richstone L; Schanne F; Stricker H; Thomas R; Wiklund P; Wilding G; Guru KA
BJU Int; 2011 Feb; 107(4):642-6. PubMed ID: 20575975
[TBL] [Abstract][Full Text] [Related]
49. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
50. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma.
Ficarra V; Dalpiaz O; Alrabi N; Novara G; Galfano A; Artibani W
BJU Int; 2005 Apr; 95(6):786-90. PubMed ID: 15794783
[TBL] [Abstract][Full Text] [Related]
51. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
Zaghloul MS
J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
[No Abstract] [Full Text] [Related]
52. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
[TBL] [Abstract][Full Text] [Related]
53. Hospital lymph node counts and survival after radical cystectomy.
Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
55. Lymph node density: surrogate marker for quality of resection in bladder cancer?
Kamat AM; Fisher MB
Expert Rev Anticancer Ther; 2007 Jun; 7(6):777-9. PubMed ID: 17555386
[No Abstract] [Full Text] [Related]
56. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN
Urol J; 2008; 5(2):94-8. PubMed ID: 18592461
[TBL] [Abstract][Full Text] [Related]
57. Lymphadenectomy in bladder cancer: a review.
Buscarini M; Josephson DY; Stein JP
Urol Int; 2007; 79(3):191-9. PubMed ID: 17940349
[TBL] [Abstract][Full Text] [Related]
58. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
Stein JP; Skinner DG
BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
[No Abstract] [Full Text] [Related]
59. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
60. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.
Kurahashi T; Hara I; Oka N; Kamidono S; Eto H; Miyake H
Clin Cancer Res; 2005 May; 11(10):3773-7. PubMed ID: 15897575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
